指南与共识瓣膜外科

指南导向同期三尖瓣成形术治疗功能性三尖瓣反流的结局

Outcomes of Guideline-Directed Concomitant Annuloplasty for Functional Tricuspid Regurgitation.
指南 / 共识 · Ann Thorac Surg · 2019-08-31

该研究回顾了171例接受左侧瓣膜手术并按指南行同期三尖瓣成形的患者,排除功能性二尖瓣反流、风湿病、活动性心内膜炎及合并冠脉搭桥或复杂主动脉手术者。结果显示30天死亡率0.6%,新置起搏器率4.1%,1年生存率95%±4%,6个月无中度及以上三尖瓣反流率93%±6%,右心室尺寸无显著增加。结论认为指南导向同期三尖瓣成形安全有效,应鼓励遵循指南。

要点

  • 指南导向同期三尖瓣成形术后30天死亡率0.6%,新置起搏器率4.1%。
  • 6个月无中度及以上三尖瓣反流率为93%±6%,3年为89%±8%。
  • 1年超声亚组分析显示右心室尺寸及面积无显著增加。

核心结论

  • 指南导向同期三尖瓣成形术治疗功能性三尖瓣反流的安全性和生存结局良好,应鼓励遵循现行指南。

研究设计与样本

  • 回顾性队列研究,纳入2012年5月至2016年3月连续171例接受左侧瓣膜手术(退行性二尖瓣手术或主动脉瓣置换)并按指南行同期三尖瓣成形的患者。

主要发现

  • 平均年龄68±12岁,女性占47%(81/171),术前房颤占57%(98/171),术前三尖瓣反流中度及以上占64%(108/171)。
  • 30天死亡率为0.6%(1/171),新置起搏器率为4.1%(7/171)。
  • 估计生存率1年为95%±4%,5年为92%±5%。
  • 无中度及以上残留/复发三尖瓣反流率6个月为93%±6%,3年为89%±8%。
  • 1年超声亚组分析显示右心室尺寸或面积无显著增加;平均超声随访14.1个月,平均临床随访33.9个月。

临床怎么用

  • 对于接受左侧瓣膜手术的功能性三尖瓣反流患者,按指南行同期三尖瓣成形术安全可行,术后复发率低且右心室重构稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite guideline recommendations, rates of concomitant tricuspid valve repair are suboptimal, possibly due to fear of complications. We reviewed morbidity, mortality, recurrent tricuspid regurgitation, and right ventricular remodeling after guideline-directed concomitant tricuspid valve repair. METHODS: We performed guideline-directed concomitant tricuspid valve repair on 171 consecutive patients who underwent left-sided valve surgery (degenerative mitral surgery or aortic valve replacement) between May 2012 and March 2016. Exclusion criteria included functional mitral regurgitation, rheumatic disease, active endocarditis, and concomitant coronary artery bypass grafting or complex aortic surgery. RESULTS: Mean age was 68 ± 12 years, and 47% (81 of 171) were women. Preoperative atrial fibrillation was present in 57% (98 of 171), and preoperative tricuspid regurgitation was moderate or higher in 64% (108 of 171). The rate of de novo pacemaker placement was 4.1% (7 of 171), and the 30-day mortality rate was 0.6% (1 of 171). Estimated survival was 95% ± 4% at 1 year and 92% ± 5% at 5 years. Freedom from moderate or worse residual/recurrent tricuspid regurgitation was 93% ± 6% at 6 months and 89% ± 8% at 3 years. Quantitative echocardiography found no significant increase in right ventricular dimensions or area at 1 year in subgroup analysis. Mean echocardiographic follow-up was 14.1 months, and mean clinical follow-up was 33.9 months. CONCLUSIONS: Guideline-directed concomitant tricuspid valve repair resulted in excellent safety end points and survival. At 14 months, freedom from moderate or worse tricuspid regurgitation was high, right ventricular performance did not worsen, and the pacemaker rate was comparable to rates after isolated mitral repair. Given these findings, adherence to current guidelines regarding functional tricuspid regurgitation should be encouraged.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Brescia AA, Ward ST, Watt TMF, et al. Outcomes of Guideline-Directed Concomitant Annuloplasty for Functional Tricuspid Regurgitation. Ann Thorac Surg. 2019. PMID: 31479635. doi:10.1016/j.athoracsur.2019.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。